Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sirt1/2-IN-2 (compound hsa55) is a dual inhibitor, targeting SIRT1 with an IC50 of 1.8 μM and SIRT2 with an IC50 of 2.4 μM. It effectively inhibits p53 deacetylation while enhancing the acetylation of p53 and α-tubulin, promoting apoptosis and exhibiting anti-proliferative effects on human leukemia cell lines [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Sirt1/2-IN-2 (compound hsa55) is a dual inhibitor, targeting SIRT1 with an IC50 of 1.8 μM and SIRT2 with an IC50 of 2.4 μM. It effectively inhibits p53 deacetylation while enhancing the acetylation of p53 and α-tubulin, promoting apoptosis and exhibiting anti-proliferative effects on human leukemia cell lines [1]. |
In vitro | Sirt1/2-IN-2 (compound hsa55) induces apoptosis in various tumor cell lines at 5 μM over 48 hours, with IC50 values of 13 μM for MV4-11, 11.5 μM for MOLM-13, 34.4 μM for THP1, and 27.5 μM for Jurkat cells [1]. At 100 μM for 30 minutes, it reduces the thermal stability of SIRT1 and SIRT2 proteins at different temperatures. At 25 μM and 30 μM over 24 hours, the compound increases acetylated p53 and α-tubulin levels in MOLM-13 cells [1]. |
Molecular Weight | 398.46 |
Formula | C18H14N4O3S2 |
Cas No. | 670267-73-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.